Animal models of ischemic stroke. Part one: modeling risk factors.
Ischemic stroke is one of the leading causes of long-term disability and death in developed and developing countries. As emerging disease, stroke related mortality and morbidity is going to step up in the next decades. This is both due to the poor identification of risk factors and persistence of unhealthy habits, as well as to the aging of the population. To counteract the estimated increase in stroke incidence, it is of primary importance to identify risk factors, study their effects, to promote primary and secondary prevention, and to extend the therapeutic repertoire that is currently limited to the very first hours after stroke. While epidemiologic studies in the human population are essential to identify emerging risk factors, adequate animal models represent a fundamental tool to dissect stroke risk factors to their molecular mechanism and to find efficacious therapeutic strategies for this complex multi- factorial disorder. The present review is organized into two parts: the first part deals with the animal models that have been developed to study stroke and its related risk factors and the second part analyzes the specific stroke models. These models represent an indispensable tool to investigate the mechanisms of cerebral injury and to develop novel therapies.
Bacigaluppi
Marco
M
Department of Neurology, University Hospital Zurich (USZ), Zurich, Switzerland.
Comi
Giancarlo
G
Hermann
Dirk M
DM
Circulation. 2004 Feb 10;109(5):647-55
14744975
Am J Physiol. 1991 Jan;260(1 Pt 2):H136-45
1992792
Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):656-60
12615675
Nature. 1996 Oct 24;383(6602):707-10
8878478
N Engl J Med. 1999 Jan 14;340(2):115-26
9887164
J Cereb Blood Flow Metab. 2008 Dec;28(12):1877-91
18698331
Stroke. 1997 Sep;28(9):1840-4
9303034
Nature. 1993 Apr 29;362(6423):801-9
8479518
Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):630-7
11950702
Nat Biotechnol. 2007 Aug;25(8):838-40
17687351
N Engl J Med. 1995 Feb 2;332(5):286-91
7816063
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12764-9
11027305
Cell Mol Neurobiol. 2004 Oct;24(5):639-46
15485135
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1585-9
7878023
Cell. 1992 Oct 16;71(2):343-53
1423598
ILAR J. 1997;38(3):109-118
11528052
JAMA. 2002 Oct 23-30;288(16):2015-22
12387654
Nat Genet. 1997 Aug;16(4):364-7
9241273
Life Sci. 2000 Dec 15;68(4):457-65
11205894
Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):372-7
11231916
Lancet Neurol. 2004 Apr;3(4):227-35
15039035
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2333-40
9409199
N Engl J Med. 2006 Apr 13;354(15):1567-77
16531613
N Engl J Med. 2006 Apr 13;354(15):1578-88
16531614
Hypertension. 1982 Nov-Dec;4(6):753-63
6754600
Nat Med. 1997 Jun;3(6):600-1
9176478
Stroke. 1996 Sep;27(9):1459-66
8784113
Science. 1988 Apr 29;240(4852):622-30
3283935
J Cardiovasc Pharmacol. 1998 Apr;31(4):540-4
9554802
Pharmacol Biochem Behav. 2007 May;87(1):179-97
17521716
NeuroRx. 2005 Jul;2(3):396-409
16389304
J Cereb Blood Flow Metab. 2002 Jul;22(7):767-73
12142561
J Clin Invest. 1993 Aug;92(2):883-93
8349823
Circulation. 2001 Jul 24;104(4):448-54
11468208
J Exp Med. 1964 Mar 1;119:425-32
14129713
J Clin Invest. 1994 May;93(5):1885-93
8182121
Am J Hum Genet. 1985 Jan;37(1):1-31
3872065
Stroke. 1993 Jan;24(1):122-5
8418535
Cardiovasc Res. 1998 Jul;39(1):77-88
9764191
N Engl J Med. 1997 Nov 6;337(19):1360-9
9358131
Hypertension. 2004 Oct;44(4):398-404
15326093
Kidney Int. 1994 Dec;46(6):1528-32
7699997
JAMA. 2004 Feb 4;291(5):565-75
14762035
Acta Physiol Scand. 2003 Nov;179(3):243-50
14616240
JAMA. 2003 May 21;289(19):2560-72
12748199
Am J Hypertens. 1990 Jan;3(1):55-8
2302329
Hum Mol Genet. 2001 Mar 1;10(5):433-43
11181567
Stroke. 2007 Apr;38(4):1396
17347469
J Clin Invest. 2001 Mar;107(6):675-83
11254667
J Cereb Blood Flow Metab. 1999 Nov;19(11):1238-46
10566970
Stroke. 2006 Feb;37(2):345-50
16397184
Lancet. 2003 Apr 19;361(9366):1391; author reply 1391-2
12711500
Am J Pathol. 2003 Jan;162(1):329-42
12507916
Cell Death Differ. 2004 Jul;11 Suppl 1:S56-64
15243582
J Clin Invest. 1998 Mar 1;101(5):1184-94
9486990
Hypertension. 1996 Jan;27(1):32-5
8591884
J Lab Clin Med. 1971 Sep;78(3):369-79
5092858
J Clin Invest. 1993 Dec;92(6):3029-37
8254057
Nat Genet. 1992 Jul;1(4):267-72
1363813
ILAR J. 1997;38(3):104-109
11528051
J Clin Invest. 1995 May;95(5):2246-57
7738190
N Engl J Med. 1987 May 28;316(22):1371-5
3574413
FASEB J. 2001 Dec;15(14):2623-30
11726538
Am J Med Sci. 2002 Jan;323(1):3-10
11814139
Exp Gerontol. 1997 Jan-Apr;32(1-2):117-27
9088909
Kidney Int. 1979 Sep;16(3):394-403
529685
Lancet Neurol. 2007 Feb;6(2):149-61
17239802
J Thromb Haemost. 2005 Aug;3(8):1646-54
16102030
Circulation. 2007 Jul 24;116(4):363-5
17646593
Comp Med. 2004 Oct;54(5):486-96
15575362
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10335-40
9294211
Lancet. 2006 May 27;367(9524):1747-57
16731270
Scand Cardiovasc J. 2002 Dec;36(6):362-7
12626204
Arteriosclerosis. 1981 Sep-Oct;1(5):293-311
6287982
Hypertension. 1995 Feb;25(2):207-13
7843770
Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1006-14
15087308
Jpn Circ J. 1963 Mar;27:282-93
13939773
N Engl J Med. 1998 Apr 9;338(15):1042-50
9535670
Arterioscler Thromb. 1994 Jan;14(1):141-7
8274470
J Clin Invest. 2001 May;107(10):1263-73
11375416
Circulation. 2001 Jun 26;103(25):3099-104
11425775
Mech Ageing Dev. 1981 Oct;17(2):183-94
7311623
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2032-8
11742881
Circulation. 2006 Jun 20;113(24):e873-923
16785347
Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):499-505
11884297
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1262-7
12538880
Nat Med. 1996 Apr;2(4):386-9
8597939